Tc Biopharm (Holdings) Plc盘中异动早盘快速下挫5.04%报1.88美元_老虎社区_美港股上老虎

Tc Biopharm (Holdings) Plc盘中异动早盘快速下挫5.04%报1.88美元

市场透视10-25 21:41

北京时间2024年10月25日21时41分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现异动，股价快速下挫5.04%。截至发稿，该股报1.88美元/股，成交量4.2149万股，换手率7.37%，振幅3.89%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.21百万美元，每股收益-27.95美元，毛利-161055.52美元，市盈率-0.01倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2478893345?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-25 21:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2478893345","market":"us","top_or_hot":-1,"title":"Tc Biopharm (Holdings) Plc盘中异动 早盘快速下挫5.04%报1.88美元","media":"市场透视","content":"<div>\n<p>北京时间2024年10月25日21时41分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现异动，股价快速下挫5.04%。截至发稿，该股报1.88美元/股，成交量4.2149万股，换手率7.37%，振幅3.89%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.21百万美元，每股收益-27.95美元，毛利-161055.52美元，市盈率-0.01倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214148971a2539&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tc Biopharm (Holdings) Plc盘中异动 早盘快速下挫5.04%报1.88美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTc Biopharm (Holdings) Plc盘中异动 早盘快速下挫5.04%报1.88美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-25 21:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214148971a2539&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月25日21时41分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现异动，股价快速下挫5.04%。截至发稿，该股报1.88美元/股，成交量4.2149万股，换手率7.37%，振幅3.89%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.21百万美元，每股收益-27.95美元，毛利-161055.52美元，市盈率-0.01倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214148971a2539&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214148971a2539&s=b","article_id":"2478893345","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214148971a2539&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2478893345","pubTimestamp":1729863708,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月25日21时41分，Tc Biopharm  Plc股票出现异动，股价快速下挫5.04%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.74%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BK4183":"个人用品","TCBP":"TC BioPharm","ELAB":"Elevai Labs, Inc."},"translate_title":"Intraday changes in Tc Biopharm (Holdings) Plc fell rapidly 5.04% to $1.88 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TCBP":0.9,"ELAB":0.87},"content_text":"北京时间2024年10月25日21时41分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现异动，股价快速下挫5.04%。截至发稿，该股报1.88美元/股，成交量4.2149万股，换手率7.37%，振幅3.89%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-4.21百万美元，每股收益-27.95美元，毛利-161055.52美元，市盈率-0.01倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Tc Biopharm (Holdings) Plc股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 (To Pur Com)、Elevai Labs, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Monopar Therapeutics Inc.较为活跃，换手率分别为550.85%、454.32%、28.34%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)、Elevai Labs, Inc.、180 Life Sciences Corp.，振幅分别为77.79%、52.82%、35.31%。Tc Biopharm (Holdings) Plc公司简介：TC BioPharm (Holdings) PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T（缩写为 GD-T）细胞平台的新型免疫治疗产品。 利用 GD-T 的先天能力，该公司能够开发出一系列旨在对抗癌症和病毒感染的临床阶段细胞疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}